Company

Novartis

Swiss giant

Basel, OS

Disclosed deals

Every published round Novartis took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.

Company	Stage	Announced	Amount	Role	Alongside	Sources
No published deals recorded yet.

Portfolio

Companies Novartis has backed in a published round, and companies whose existing shares it bought off another holder.

Company	What it does	First invested	Rounds	Led
No portfolio companies recorded yet.

Funds

Fund closes reported for Novartis, as distinct from the investments it has made.

Fund	Announced	Committed	Target	Close	Sources
No fund closes recorded for Novartis yet.

Portfolio companies acquired

Companies Novartis has backed that another company then bought. An exit for the holding, not a deal Novartis did.

Company	Bought by	Kind	Announced	Price
No portfolio company of Novartis is recorded as having been acquired.

What Novartis bought

Companies Novartis acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Spinifex Pharmaceuticals	Acquisition	29 Jun 2015	US$700m (A$911m)	Startup Daily (24 Jul 2025), Business News Australia, materresearch.org.au, @AuManufacturing, Startup Daily (15 Nov 2023), GBS Ventures (8 Sep 2016), anthillonline.com, GBS Ventures (30 Jun 2015), clinicalleader.com, novartis.com

Name	Role	Sources
David Epstein	Head of Novartis Pharmaceuticals	novartis.com

Something wrong? Tell us

Novartis

Disclosed deals

Portfolio

Funds

Portfolio companies acquired

What Novartis bought

People

Coverage

Brandon Capital's $60m taypayer-funded biotech bets

Brisbane biotech AdvanCell just raised a record $450 million

Brandon Capital scores its biggest return ever with $2.1bn biotech acquisition

Sanofi's mega US$1.6 billion Vicebio buyout once again shows the value of Aussie uni IP

UQ biotech innovation partnership forges a second startup

Professor got nothing from the $2.8b sale of his molecule, and that's okay

Manufacturing news briefs – stories you might have missed

Manufacturing news briefs — stories you might have missed

Pioneering VC fund Uniseed doubles its backers as five universities, including Monash, UTS and Macquarie, chip in

Brandon Capital news

Uniseed invests $1m in PERKii's $4m funding round

Australian pain drug innovation company Spinifex Pharmaceuticals sold to Novartis for US$200m plus milestone payments